Organ Preservation Market By Preservation Technique (Static Cold Storage (SCS), Hypothermic Machine Perfusion (HMP), Normothermic Machine Perfusion (NMP), Controlled Oxygenated Rewarming, and Subnormothermic Machine Perfusion). By Organ type, (kidneys, liver, heart, lungs, pancreas, small Intestine, and Composite tissue (e.g., limbs, faces). By solution, (UW (University of Wisconsin) Solution, Custodiol HTK Solution, Perfadex Solution, Celsior Solution, Steen Solution, and others). By Application, (Organ transplantation, Organ Research & Development, and Training & Education). By Organ Condition, (Deceased Donor Organs and living donor organs). By end-users, (Hospitals, Transplant centers, Organ Procurement Organizations, and Research & Academic Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

Industry Outlook

The Organ Preservation Market accounted for USD 316.8 Million in 2024 and is expected to reach USD 646.5 Million by 2035, growing at a CAGR of around 6.7% between 2025 and 2035. The Organ Preservation Market concerns the technology and solutions relating to the storage of human organs in a state viable for transplanting. Its area of concern extends to preservation solutions, machines, and devices for keeping an organ outside the human body alive, or at least causing no injury while it is transported.

Among such innovations would also be considered improvements in function achieved by machine perfusion in preparing an organ for its eventual transplanting. The increasing demand for organ transplants requires advancement in organ preservation to solve the shortage of organs and improve the care of patients. The market is growing due to increased awareness, technological advancement, and the increasing number of transplant procedures.

Report Scope:

Market Dynamics

Rising organ failure rates and increasing transplant demands globally are placing immense pressure on healthcare systems and resources.

Increasing rates of organ failure and the want for transplants are putting a tremendous burden on the health systems of the world, thus representing a big challenge in serving the needs of the patients, which drives the Organ Preservation Market growth. The increasing prevalence of chronic diseases such as diabetes, hypertension, and liver disease contribute to increased rates of organ failure, thereby increasing the demand for transplants.

Pressure is further increased by increased demand because there aren't enough donor organs available. With the additional requirement for sophisticated organ preservation technology, the level of competition increases. To bridge the gap between organ donation and transplantation, the Organ Preservation Market intervenes by providing technologies that prolong the organ's life until it is viable for transplantation. According to the NIH, there are over 107,000 people in the US waiting for organ transplants, highlighting the urgent need for action. Innovations and immediate infrastructure are needed in the organ preservation industry. By offering better preservation and transportation options, infrastructure and technology advancements play a critical role in enhancing the results of organ transplantation. Healthcare strategies for expanding demands can meet these objectives by implementing donor awareness and organ donation systems. The strain placed on the transplant ecosystem would be shared by government collaboration, research facilities, and medical services.

Advancements in cryopreservation improve organ storage methods, enhancing transplantation and preservation possibilities.

Advancements in cryopreservation in the Organ Preservation Market are changing the method of preserving organs. This preserves organs for a longer time, and safer preservation is done without any ice crystal formation. Advanced cryoprotectants and vitrification protect organs against ice crystallization and keep their structure and functions intact when they are thawed. It has directly come up with a major problem concerning organ transplantation: short storage times, which in turn lead to waste.

NIH reports that enhanced preservation techniques will result in a 20% increase in the rate of organ usage, thus saving thousands of people every year. It also enables the preservation of more complex organs like hearts and lungs for longer periods than before, which was impossible to do. Greater storage technology enhances large-sized organ-sharing networks and consequently will promote enhanced transplantation into more distanced areas. Consequently, a tremendous growth rate is projected to rise in the preservation market for the organ. Increasing numbers of agreements will exist among biotechnology corporations, research agencies, and hospitals due to demand from this high source for good organs.

Donor scarcity and ethical issues challenge organ donation practices globally.

The lack of donors and the presence of ethical concerns heavily confine the Organ Preservation Market by restricting the supply of organs for transplantation. Due to the scarcity of donor populations globally, supply-side challenges of preservation procedures translate to a relatively low occurrence of organ transplants. The entire procedure is made even more morally dubious by the numerous equity concerns, such as the fair distribution of essential organs and the problems with informed permission. Organ donation is slowed down in many places by several unsettling legislative restrictions on collectivism, as well as cultural and religious ones. These obstacles hinder the development and application of advanced preservation methods, which are backup products whose market expansion depends on a steady supply of organs.

Emerging economies experience significant growth in healthcare infrastructure development.

One of the key factors influencing the Organ Preservation Market is the growing healthcare infrastructure in emerging economies, which is rapidly expanding in the global arena. Growths in hi-tech medical facilities and equipment are extending the ability to execute complicated surgeries and inclusive organ transplants. The entire procedure is made even more morally dubious by the numerous equity concerns, such as the fair distribution of essential organs and the problems with informed permission.

Organ donation is slowed down in many places by several unsettling legislative restrictions on collectivism, as well as cultural and religious ones. These obstacles hinder the development and application of advanced preservation methods, which are backup products whose market expansion depends on a steady supply of organs. For this field to develop responsibly, these questions must be answered.

Research on bioengineering focuses on creating synthetic and regenerative organs for medical applications.

Bioengineering research has developed synthetic and regenerative organs that will change medical treatments forever; this acts as a significant opportunity for the market. This includes using advanced materials, stem cells, and tissue engineering in the development of functional organs or the repair of damaged ones. Bioengineers can develop organs with the use of 3D bioprinting and gene editing technologies that can be used for transplantation purposes and may not have to depend on donor organs. Other research areas include regenerative medicine, which aims to stimulate the body's healing processes to repair or regenerate tissue. The hope is to avoid organ shortages and treat patients with chronic organ failure with better outcomes.

Major institutions like the Massachusetts Institute of Technology (MIT) are pushing science forward with efforts to combine expertise in engineering, biology, and medicine toward achieving the highest degree of possible progress in organ regeneration and synthetic organ design. Synthesis and regeneration of organs are accelerating innovation with the collaborative work of universities, hospitals, and biotechnology companies. All these findings could not only improve organ transplantation but also provide patients with different conditions related to various tissues and organs with new ways of treatment.

Industry Experts Opinion

“Advancements in preservation techniques are crucial for improving transplant outcomes and ensuring that more patients receive the life-saving organs they need”.

-According to Jason Acker, a professor of laboratory medicine and pathology at the University of Alberta

“The key to increasing organ donation is to ensure that families have the opportunity to discuss their wishes with each other and to register as donors”

 -Dr. David Klassen, Chief Medical Officer of the United Network for Organ Sharing (UNOS), states

Segment Analysis

Based on the preservation technique, the Organ Preservation Market has been classified into static cold storage (SCS), hypothermic machine perfusion (HMP), normothermic machine perfusion (NMP), controlled oxygenated rewarming, and sub-normothermic machine perfusion. Hypothermic machine perfusion (HMP) is one of the most important and dominant techniques in the Organ Preservation Market. HMP preserves organs at low temperatures, using a cold preservation solution perfused through them to reduce the effects of ischemic injury on organs and, thereby, on their function. It has been successful mainly in the cases of kidney and liver transplantation as it improved graft quality and prolonged organ viability.

HMP is superior to SCS in that it not only cools the organs but also actively perfuses them. This is where HMP shows better outcomes regarding damage reduction and post-transplant function improvement. It's able to preserve the metabolism of the organ as well as the oxygenation of the organ, thus making preservation times longer. This results in HMP being widely accepted in clinical practice. It is considered one of the most promising techniques for a better transplant outcome. The technique is also increasingly being assimilated into the research and development of refining preservation methods for other transplantable organs. The body reconstruction products segment dominated the market of organ preservation with a major market share. 

Based on the organ type, the Organ Preservation Market has been classified into kidneys, liver, heart, lungs, pancreas, small intestine, and composite tissue. The most significant portion of the Organ Preservation Market is the kidneys segment. This is highly attributed to the general demand for kidney transplantation. Kidney transplants are among the most commonly performed procedures, making kidney preservation critical. With a growing number of people experiencing chronic kidney disease, combined with a lack of available donor organs, a need remains unmet and drives the call for more effective preservation methods.

Techniques like hypothermic machine perfusion have advanced kidney preservation, making the kidneys viable outside the body for a longer period. Since kidneys are relatively more resistant than other organs, their preservation is more feasible, which further cements their position. The development of preservation technologies specifically tailored to kidneys, such as static cold storage and machine perfusion, has led to better transplant outcomes. Furthermore, higher success rates for kidney transplants over other organ types make it important to preserve the organs. As the demand grows and the techniques of preservation continue to evolve, kidneys remain the largest market segment.

Regional Analysis

The North American Organ Preservation Market has the highest share and is expected to dominate this cervical fusion market because of several underlying key factors. The first advantage gives North America a significant edge in terms of the advanced healthcare infrastructure and cutting-edge research in organ preservation technologies. The second factor is mainly attributed to the growing demand for organ transplants, coupled with a high prevalence of organ failure. Third, government initiatives and funding support innovations in preservation solutions. It has good health and research institute relationships.

Techniques such as hypothermic and normothermic perfusion to better preserve the transplanted parts are of key importance. Expertise in device manufacturing will promote the development of devices used in preserving the transplanted organs. Organ transplantation is sometimes required on precise time scales and also for the viability of organs, such as in the case of cervical fusion. All these can only be guaranteed if there are capabilities as are evident in North America. In addition, the region's well-established regulatory environment ensures quality standards for organ preservation products. All these factors collectively position North America as a dominant force in both organ preservation and cervical fusion markets.

The Asia Pacific Organ Preservation Market is one of the most booming markets and is growing at a remarkable rate, with multiple growth factors. Improved awareness of oral health, a higher disposable income, and more technological innovations also play a big role in these expansions. India, China, and Japan show rapid urbanization and population rise, which consequently increases the demand for advanced dental care solutions.

The growing number of dental professionals and clinics is also increasing access to dental treatments. Improvements in caries detection technology include more accurate and user-friendly devices, which aid in better detection and treatment. Governments in the region are taking active measures to spread awareness about dental care through various initiatives and campaigns that support market growth. The region will likely be the biggest market for dental caries detectors as health infrastructure improves and affordability is enhanced.

Competitive Landscape

The Organ Preservation Market is very competitive, with most of the leading companies trying to innovate further on organ storage, transportation, and viability. Amongst the leaders of current advancement are TransMedics and XVIVO in more advanced technologies for perfusion systems and preservation solutions. Bridge to Life Ltd specializes in innovations for storage technologies of the organs, paragonix Technologies, and OrganOx, improving the function of machine perfusion devices meant to optimize viability.

Preservation solutions are provided by Organ Recovery Systems, Waters Medical Systems, and preservation products by Dr. Franz Köhler Chemie GmbH—a subsidiary with a portfolio from CryoLife. 21st Century Medicine and Shanghai Genext Medical Technology contribute to the latest research and biotechnological developments in the field. Biolife Solutions is experienced in cell preservation, which is of extreme importance in enhancing transplantation outcomes. Global Transplant Solutions specializes in full-service organ recovery services and is one of the leading companies in this sector. These companies are changing the face of organ preservation technologies by fostering the growth of transplantation procedures around the world.

Organ Preservation Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In November 2024, XVIVO completed enrollment for the PRESERVE clinical trial, evaluating their heart technology's safety and effectiveness, achieving this milestone five months ahead of schedule with 141 patients transplanted.
• In October 2024, Bridge to Life and ULS Coimbra announced a collaboration to enhance liver preservation for transplantation, launching case studies to highlight innovative procedures at ULS Coimbra's liver transplant program

Report Coverage:

By Preservation Technique

• Static Cold Storage (SCS)
• Hypothermic Machine Perfusion (HMP)
• Normothermic Machine Perfusion (NMP)
• Controlled Oxygenated Rewarming
• Subnormothermic Machine Perfusion

By Organ Type

• Kidneys
• Liver
• Heart
• Lungs
• Pancreas
• Small Intestine
• Composite Tissue

By Solution

• UW (University of Wisconsin) Solution
• Custodiol HTK Solution
• Perfadex Solution
• Celsior Solution
• Steen Solution
• Others

 By Application

• Organ Transplantation
• Organ Research & Development
• Training & Education

By Organ Condition

• Deceased Donor Organs
• Living Donor Organs

By End-user

• Hospitals
• Transplant Centers
• Organ Procurement Organizations
• Research & Academic Institutions

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• TransMedics
• XVIVO
• Bridge to Life Ltd.
• Paragonix Technologies
• OrganOx
• Preservation Solutions
• Organ Recovery Systems
• Waters Medical Systems
• Global Transplant Solutions
• CryoLife
• Dr. Franz Köhler Chemie GmbH
• Essential Pharmaceuticals
• 21st Century Medicine
• Shanghai Genext Medical Technology
• Biolife Solutions

Frequently Asked Questions (FAQs)